Added to YB: 2025-08-29
Pitch date: 2025-08-27
COV.V [neutral]
Covalon Technologies Ltd.
-19.98%
current return
Author Info
Stocks & Stones manages the Rivemont MicroCap Fund, which has several million $ in assets. I’m here to help you avoid the pitfalls of microcap investing. Sign up for the newsletter.
Company Info
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
Market Cap
CAD 65.8M
Pitch Price
CAD 2.21
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.34
P/E
27.87
EV/Sales
1.48
Sector
Biotechnology
Category
value
Second Quarter 2025 Earnings Recap - Covalon Technologies Ltd.
COV.V (earnings update): Q4 disappointed w/ 9% YOY revenue decline, net income nearly vanished despite CEO's prior positive outlook. Mgmt cherry-picked favorable metrics, poor communication eroded shareholder trust. Stock -19% post-earnings but strategic review underway as potential catalyst. Remains undervalued long-term.
Read full article (2 min)